| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 3.94e-05 | 22 | 178 | 4 | GO:0004115 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 5.64e-05 | 24 | 178 | 4 | GO:0047555 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 6.67e-05 | 25 | 178 | 4 | GO:0004114 | |
| GeneOntologyMolecularFunction | cAMP binding | 6.67e-05 | 25 | 178 | 4 | GO:0030552 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 9.13e-05 | 27 | 178 | 4 | GO:0004112 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.67e-04 | 130 | 178 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | spectrin binding | 2.30e-04 | 34 | 178 | 4 | GO:0030507 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 3.94e-04 | 39 | 178 | 4 | GO:0030551 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.17e-04 | 151 | 178 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 4.69e-04 | 4 | 178 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 5.15e-04 | 18 | 178 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.01e-03 | 227 | 178 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.06e-03 | 129 | 178 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.16e-03 | 6 | 178 | 2 | GO:0048763 | |
| GeneOntologyBiologicalProcess | cAMP catabolic process | 6.39e-07 | 9 | 177 | 4 | GO:0006198 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 2.03e-06 | 25 | 177 | 5 | GO:0046058 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide catabolic process | 4.91e-06 | 14 | 177 | 4 | GO:0009214 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell contraction | 3.25e-05 | 43 | 177 | 5 | GO:0086004 | |
| GeneOntologyBiologicalProcess | cyclic purine nucleotide metabolic process | 3.64e-05 | 44 | 177 | 5 | GO:0052652 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide metabolic process | 4.07e-05 | 45 | 177 | 5 | GO:0009187 | |
| GeneOntologyBiologicalProcess | negative regulation of relaxation of cardiac muscle | 7.32e-05 | 2 | 177 | 2 | GO:1901898 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based movement | 9.04e-05 | 53 | 177 | 5 | GO:1903115 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 9.57e-05 | 166 | 177 | 8 | GO:0014074 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 9.75e-05 | 11 | 177 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 1.21e-04 | 30 | 177 | 4 | GO:0098901 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 2.11e-04 | 14 | 177 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | cellular response to epinephrine stimulus | 2.11e-04 | 14 | 177 | 3 | GO:0071872 | |
| GeneOntologyBiologicalProcess | regulation of SA node cell action potential | 2.18e-04 | 3 | 177 | 2 | GO:0098907 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.07e-07 | 73 | 179 | 8 | GO:0034704 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 2.56e-06 | 46 | 179 | 6 | GO:0005891 | |
| GeneOntologyCellularComponent | I band | 1.35e-05 | 166 | 179 | 9 | GO:0031674 | |
| GeneOntologyCellularComponent | myofibril | CACNA1S FLNB PDE4B PDE4D ANK2 ANK3 SPTAN1 RYR2 RYR3 SVIL VCL | 2.46e-05 | 273 | 179 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | intercalated disc | 2.56e-05 | 68 | 179 | 6 | GO:0014704 | |
| GeneOntologyCellularComponent | costamere | 3.37e-05 | 22 | 179 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | contractile muscle fiber | CACNA1S FLNB PDE4B PDE4D ANK2 ANK3 SPTAN1 RYR2 RYR3 SVIL VCL | 4.28e-05 | 290 | 179 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | Z disc | 4.85e-05 | 151 | 179 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 1.10e-04 | 88 | 179 | 6 | GO:0016529 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.58e-04 | 94 | 179 | 6 | GO:0044291 | |
| GeneOntologyCellularComponent | fascia adherens | 1.66e-04 | 13 | 179 | 3 | GO:0005916 | |
| GeneOntologyCellularComponent | sarcolemma | 2.39e-04 | 190 | 179 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | anchoring junction | FLNB FLT1 HYOU1 ANK2 ANK3 DSG2 PSG6 SPTAN1 SPECC1L VSIG10 PFN1 AFAP1L1 TGFBR1 FRMD4A HEG1 TLN1 SVIL DEF6 TLN2 VCL | 2.75e-04 | 976 | 179 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | sarcomere | 3.06e-04 | 249 | 179 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | sarcoplasm | 4.50e-04 | 114 | 179 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | cell-cell junction | ANK2 ANK3 DSG2 PSG6 SPTAN1 SPECC1L VSIG10 TGFBR1 FRMD4A HEG1 TLN1 DEF6 TLN2 VCL | 5.89e-04 | 591 | 179 | 14 | GO:0005911 |
| GeneOntologyCellularComponent | cation channel complex | 9.74e-04 | 235 | 179 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.06e-03 | 90 | 179 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment | 1.37e-03 | 141 | 179 | 6 | GO:0005793 | |
| GeneOntologyCellularComponent | coated membrane | 2.20e-03 | 106 | 179 | 5 | GO:0048475 | |
| GeneOntologyCellularComponent | membrane coat | 2.20e-03 | 106 | 179 | 5 | GO:0030117 | |
| GeneOntologyCellularComponent | clathrin adaptor complex | 2.33e-03 | 31 | 179 | 3 | GO:0030131 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 2.52e-03 | 9 | 179 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | spectrin | 2.52e-03 | 9 | 179 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | vesicle coat | 2.62e-03 | 67 | 179 | 4 | GO:0030120 | |
| Domain | Clathrin/coatomer_adapt-like_N | 1.84e-07 | 15 | 174 | 5 | IPR002553 | |
| Domain | Adaptin_N | 1.84e-07 | 15 | 174 | 5 | PF01602 | |
| Domain | Coatomer/calthrin_app_sub_C | 4.95e-07 | 8 | 174 | 4 | IPR009028 | |
| Domain | ARM-type_fold | COPG1 INTS7 COPG2 ECPAS AP3B1 RYR3 ITPR2 EFR3A MROH1 AP1B1 AP2B1 CEBPZ UTP20 HEATR5B PPP6R3 | 6.92e-07 | 339 | 174 | 15 | IPR016024 |
| Domain | B2-adapt-app_C | 3.16e-06 | 4 | 174 | 3 | SM01020 | |
| Domain | B-adaptin_app_sub_C | 3.16e-06 | 4 | 174 | 3 | IPR015151 | |
| Domain | Coatomer/clathrin_app_Ig-like | 3.40e-06 | 12 | 174 | 4 | IPR013041 | |
| Domain | - | COPG1 INTS7 COPG2 ECPAS AP3B1 EFR3A MROH1 AP1B1 AP2B1 UTP20 HEATR5B | 7.70e-06 | 222 | 174 | 11 | 1.25.10.10 |
| Domain | AP_beta | 7.84e-06 | 5 | 174 | 3 | IPR026739 | |
| Domain | ARM-like | COPG1 INTS7 COPG2 ECPAS AP3B1 EFR3A MROH1 AP1B1 AP2B1 UTP20 HEATR5B PPP6R3 | 8.94e-06 | 270 | 174 | 12 | IPR011989 |
| Domain | RIH_assoc-dom | 1.56e-05 | 6 | 174 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.56e-05 | 6 | 174 | 3 | PF08709 | |
| Domain | RIH_assoc | 1.56e-05 | 6 | 174 | 3 | PF08454 | |
| Domain | RIH_dom | 1.56e-05 | 6 | 174 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.56e-05 | 6 | 174 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.56e-05 | 6 | 174 | 3 | IPR015925 | |
| Domain | - | 1.56e-05 | 6 | 174 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.56e-05 | 6 | 174 | 3 | PF01365 | |
| Domain | PDEase | 2.53e-05 | 19 | 174 | 4 | IPR023088 | |
| Domain | Vinculin/catenin | 2.71e-05 | 7 | 174 | 3 | IPR006077 | |
| Domain | PDEase_I | 3.85e-05 | 21 | 174 | 4 | PF00233 | |
| Domain | PDEASE_I | 3.85e-05 | 21 | 174 | 4 | PS00126 | |
| Domain | PDEase_CS | 3.85e-05 | 21 | 174 | 4 | IPR023174 | |
| Domain | S1 | 4.30e-05 | 8 | 174 | 3 | PF00575 | |
| Domain | - | 4.67e-05 | 22 | 174 | 4 | 1.10.1300.10 | |
| Domain | HEAT_REPEAT | 4.80e-05 | 70 | 174 | 6 | PS50077 | |
| Domain | PDEase_catalytic_dom | 5.61e-05 | 23 | 174 | 4 | IPR002073 | |
| Domain | HD/PDEase_dom | 6.68e-05 | 24 | 174 | 4 | IPR003607 | |
| Domain | HDc | 6.68e-05 | 24 | 174 | 4 | SM00471 | |
| Domain | - | 8.63e-05 | 2 | 174 | 2 | 1.20.1420.10 | |
| Domain | Coatomer_g_Cpla | 8.63e-05 | 2 | 174 | 2 | IPR032154 | |
| Domain | - | 8.63e-05 | 2 | 174 | 2 | 2.60.40.1480 | |
| Domain | VBS | 8.63e-05 | 2 | 174 | 2 | PF08913 | |
| Domain | Vinculin-bd_dom | 8.63e-05 | 2 | 174 | 2 | IPR015009 | |
| Domain | COP-gamma_platf | 8.63e-05 | 2 | 174 | 2 | PF08752 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 8.63e-05 | 2 | 174 | 2 | IPR013037 | |
| Domain | Coatomer_g_Cpla | 8.63e-05 | 2 | 174 | 2 | PF16381 | |
| Domain | Talin_cent | 8.63e-05 | 2 | 174 | 2 | IPR015224 | |
| Domain | Coatomer_gsu_app_Ig-like-sub | 8.63e-05 | 2 | 174 | 2 | IPR013040 | |
| Domain | Talin_middle | 8.63e-05 | 2 | 174 | 2 | PF09141 | |
| Domain | XAP5 | 8.63e-05 | 2 | 174 | 2 | IPR007005 | |
| Domain | - | 8.63e-05 | 2 | 174 | 2 | 2.60.40.1150 | |
| Domain | XAP5 | 8.63e-05 | 2 | 174 | 2 | PF04921 | |
| Domain | Coatomer_gsu | 8.63e-05 | 2 | 174 | 2 | IPR017106 | |
| Domain | MIR | 9.09e-05 | 10 | 174 | 3 | PF02815 | |
| Domain | MIR_motif | 9.09e-05 | 10 | 174 | 3 | IPR016093 | |
| Domain | S1 | 9.09e-05 | 10 | 174 | 3 | PS50126 | |
| Domain | MIR | 9.09e-05 | 10 | 174 | 3 | PS50919 | |
| Domain | MIR | 9.09e-05 | 10 | 174 | 3 | SM00472 | |
| Domain | S1 | 1.64e-04 | 12 | 174 | 3 | SM00316 | |
| Domain | S1_dom | 1.64e-04 | 12 | 174 | 3 | IPR022967 | |
| Domain | S1_domain | 1.64e-04 | 12 | 174 | 3 | IPR003029 | |
| Domain | Ryanodine_rcpt | 2.57e-04 | 3 | 174 | 2 | IPR003032 | |
| Domain | AP_complex_bsu_1_2_4 | 2.57e-04 | 3 | 174 | 2 | IPR016342 | |
| Domain | Talin-1 | 2.57e-04 | 3 | 174 | 2 | IPR015710 | |
| Domain | Ryanrecept_TM4-6 | 2.57e-04 | 3 | 174 | 2 | IPR009460 | |
| Domain | RyR | 2.57e-04 | 3 | 174 | 2 | PF02026 | |
| Domain | B2-adapt-app_C | 2.57e-04 | 3 | 174 | 2 | PF09066 | |
| Domain | RR_TM4-6 | 2.57e-04 | 3 | 174 | 2 | PF06459 | |
| Domain | Ryan_recept | 2.57e-04 | 3 | 174 | 2 | IPR013333 | |
| Domain | VDCC_a2/dsu | 5.11e-04 | 4 | 174 | 2 | IPR013680 | |
| Domain | ILWEQ_dom | 5.11e-04 | 4 | 174 | 2 | IPR002558 | |
| Domain | ILWEQ | 5.11e-04 | 4 | 174 | 2 | SM00307 | |
| Domain | Retinoic_acid_rcpt | 5.11e-04 | 4 | 174 | 2 | IPR003078 | |
| Domain | FERM_f0 | 5.11e-04 | 4 | 174 | 2 | PF16511 | |
| Domain | ILWEQ | 5.11e-04 | 4 | 174 | 2 | PD011820 | |
| Domain | Clathrin_a/coatomer_app_sub_C | 5.11e-04 | 4 | 174 | 2 | IPR015873 | |
| Domain | - | 5.11e-04 | 4 | 174 | 2 | 1.20.1410.10 | |
| Domain | VGCC_alpha2 | 5.11e-04 | 4 | 174 | 2 | PF08473 | |
| Domain | I_LWEQ | 5.11e-04 | 4 | 174 | 2 | PF01608 | |
| Domain | I_LWEQ | 5.11e-04 | 4 | 174 | 2 | PS50945 | |
| Domain | FERM_f0 | 5.11e-04 | 4 | 174 | 2 | IPR032425 | |
| Domain | - | 5.11e-04 | 4 | 174 | 2 | 3.30.310.30 | |
| Domain | VWA_N | 8.47e-04 | 5 | 174 | 2 | IPR013608 | |
| Domain | VWA_N | 8.47e-04 | 5 | 174 | 2 | PF08399 | |
| Domain | Perilipin | 8.47e-04 | 5 | 174 | 2 | PF03036 | |
| Domain | Perilipin | 8.47e-04 | 5 | 174 | 2 | IPR004279 | |
| Domain | EFhand_Ca_insen | 1.26e-03 | 6 | 174 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 1.26e-03 | 6 | 174 | 2 | IPR014837 | |
| Domain | Beta2_adaptin/TBP_C_dom | 1.26e-03 | 6 | 174 | 2 | IPR012295 | |
| Domain | - | 1.26e-03 | 6 | 174 | 2 | 3.30.310.10 | |
| Domain | FERM_CS | 1.39e-03 | 24 | 174 | 3 | IPR019747 | |
| Domain | Transglut_N | 2.98e-03 | 9 | 174 | 2 | PF00868 | |
| Domain | TRANSGLUTAMINASES | 2.98e-03 | 9 | 174 | 2 | PS00547 | |
| Domain | - | 2.98e-03 | 9 | 174 | 2 | 3.90.260.10 | |
| Domain | Alpha_adaptinC2 | 2.98e-03 | 9 | 174 | 2 | PF02883 | |
| Domain | Gln_gamma-glutamylTfrase_euk | 2.98e-03 | 9 | 174 | 2 | IPR023608 | |
| Domain | Transglutaminase_AS | 2.98e-03 | 9 | 174 | 2 | IPR013808 | |
| Domain | Transglutaminase_N | 2.98e-03 | 9 | 174 | 2 | IPR001102 | |
| Domain | ZU5 | 2.98e-03 | 9 | 174 | 2 | SM00218 | |
| Domain | Transglut_C | 2.98e-03 | 9 | 174 | 2 | PF00927 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 2.98e-03 | 9 | 174 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 2.98e-03 | 9 | 174 | 2 | SM00809 | |
| Domain | FERM_N | 3.53e-03 | 33 | 174 | 3 | IPR018979 | |
| Domain | FERM_N | 3.53e-03 | 33 | 174 | 3 | PF09379 | |
| Domain | Transglutaminase_C | 3.70e-03 | 10 | 174 | 2 | IPR008958 | |
| Domain | ExoRNase_PH_dom1 | 3.70e-03 | 10 | 174 | 2 | IPR001247 | |
| Domain | ZU5 | 3.70e-03 | 10 | 174 | 2 | PS51145 | |
| Domain | - | 4.09e-03 | 333 | 174 | 9 | 2.130.10.10 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 1.26e-05 | 16 | 133 | 4 | MM14699 | |
| Pathway | WP_SILDENAFIL_TREATMENT | 5.83e-05 | 23 | 133 | 4 | M46455 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 6.62e-05 | 9 | 133 | 3 | M47725 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 6.95e-05 | 24 | 133 | 4 | M751 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.14e-04 | 156 | 133 | 8 | M27097 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.28e-04 | 11 | 133 | 3 | M47958 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 1.65e-04 | 55 | 133 | 5 | M39763 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.96e-04 | 31 | 133 | 4 | M877 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 2.05e-04 | 90 | 133 | 6 | M6467 | |
| Pubmed | FLNB HYOU1 COPG1 SPTAN1 NUP98 COPG2 ZNF318 ECPAS BIRC6 DICER1 DHX8 PNPT1 AP1B1 AP2B1 CEBPZ TLN1 CPSF1 PDCD11 UTP20 HCFC1 VCL PPP6R3 | 3.99e-12 | 653 | 179 | 22 | 22586326 | |
| Pubmed | DAB2IP HYOU1 ANK3 SPTAN1 NUP98 COPG2 PSMD13 AP3B1 BIRC6 CDC14A TAB3 ITPR2 EFR3A PPP1R2 KMT2D TBC1D31 CEBPZ SVIL MIOS CPSF1 FKBP8 PYCR2 BTRC PPP6R3 ILKAP | 2.06e-10 | 1049 | 179 | 25 | 27880917 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNB HYOU1 ANK3 COPG1 SPTA1 SPTAN1 COPG2 PSMD13 MCCC1 PIR ECPAS PFN1 AP3B1 RUVBL2 MTAP AP1B1 AP2B1 TLN1 HSPA1L MYO16 MVD VCL | 2.29e-10 | 807 | 179 | 22 | 30575818 |
| Pubmed | 6.79e-10 | 4 | 179 | 4 | 9371714 | ||
| Pubmed | Assessment of PDE4 Inhibitor-Induced Hypothermia as a Correlate of Nausea in Mice. | 6.79e-10 | 4 | 179 | 4 | 34943270 | |
| Pubmed | PAN-selective inhibition of cAMP-phosphodiesterase 4 (PDE4) induces gastroparesis in mice. | 6.79e-10 | 4 | 179 | 4 | 32738081 | |
| Pubmed | 6.79e-10 | 4 | 179 | 4 | 8413254 | ||
| Pubmed | 6.79e-10 | 4 | 179 | 4 | 22946044 | ||
| Pubmed | 6.79e-10 | 4 | 179 | 4 | 33609559 | ||
| Pubmed | 6.79e-10 | 4 | 179 | 4 | 24732776 | ||
| Pubmed | DAB2IP FLNB ANK2 ANK3 COPG1 SPTAN1 PSMD13 MCCC1 RAB6B RUVBL2 BIRC6 RYR2 TAB3 PPP1R2 FRMD4A PPP1R2B ATP2C1 OXCT1 PPP1R2P1 TLN2 RIMS1 FKBP8 PYCR2 BTRC WNK2 | 1.11e-09 | 1139 | 179 | 25 | 36417873 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNB HYOU1 COPG1 DSG2 FN3KRP NUP98 FARSB PSMD13 ECPAS PFN1 AP3B1 CDC14A DICER1 PGM3 ATP2C1 AP1B1 AP2B1 OSBPL3 TXNDC16 PYCR2 BTRC VCL PPP6R3 | 1.38e-09 | 974 | 179 | 23 | 28675297 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CACNA1S FLNB PDE4D HYOU1 COPG1 SPTAN1 NUP98 FARSB NIF3L1 PSMD13 ECPAS AP3B1 RUVBL2 BIRC6 PPP1R2 RBM12 OXCT1 MTAP AP1B1 AP2B1 TLN1 TNFAIP8 HSPA1L HCFC1 MVD VCL PPP6R3 UBFD1 | 1.88e-09 | 1455 | 179 | 28 | 22863883 |
| Pubmed | 3.38e-09 | 5 | 179 | 4 | 33944911 | ||
| Pubmed | 3.38e-09 | 5 | 179 | 4 | 8586960 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNB HYOU1 COPG1 DSG2 CACNA2D2 VPS4A SPTAN1 FN3KRP SMC6 NUP98 FARSB PSMD13 ECPAS PFN1 AP3B1 RUVBL2 DICER1 DHX8 CEBPZ TLN1 CPSF1 PDCD11 UTP20 TLN2 PYCR2 HCFC1 VCL | 5.27e-09 | 1425 | 179 | 27 | 30948266 |
| Pubmed | FLNB HYOU1 COPG1 DSG2 SPTAN1 NUP98 COPG2 PSMD13 ECPAS AP3B1 RUVBL2 AP1B1 AP2B1 TLN1 PDCD11 FKBP8 PYCR2 PPP6R3 | 6.48e-09 | 638 | 179 | 18 | 33239621 | |
| Pubmed | FLNB HYOU1 COPG1 VPS4A SPTAN1 FARSB COPG2 PSMD13 SPECC1L MCCC1 ECPAS PFN1 DICER1 PGM3 ITPR2 OXCT1 COMMD4 AP2B1 CEBPZ TLN1 VPS35L PDCD11 FKBP8 PYCR2 HCFC1 BTRC PPP6R3 | 6.57e-09 | 1440 | 179 | 27 | 30833792 | |
| Pubmed | CFAP47 FLNB HYOU1 COPG1 SPTAN1 FN3KRP PSMD13 ECPAS PFN1 RUVBL2 AP2B1 TLN1 HSPA1L HCFC1 VCL PPP6R3 | 6.89e-09 | 494 | 179 | 16 | 26831064 | |
| Pubmed | Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. | 1.01e-08 | 6 | 179 | 4 | 18923023 | |
| Pubmed | FLNB PDE4D HYOU1 ANK2 ANK3 SPTA1 SPTAN1 RBP3 FARSB SPECC1L PFN1 AP3B1 PNMA8B ITPR2 CRYM AP1B1 AP2B1 TLN1 SVIL MIOS TLN2 RIMS1 PYCR2 WNK2 VCL CACNA2D3 | 2.43e-08 | 1431 | 179 | 26 | 37142655 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 2.77e-08 | 18 | 179 | 5 | 12119179 | |
| Pubmed | ANK3 DSG2 SPTAN1 ZNF318 SPECC1L AP3B1 RUVBL2 TAB3 KMT2D CEBPZ TLN1 PDCD11 MED27 HCFC1 VCL PPP6R3 | 2.99e-08 | 549 | 179 | 16 | 38280479 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | HYOU1 COPG1 SPTAN1 FARSB PSMD13 ECPAS PFN1 RUVBL2 PGM3 RBM12 MTAP AP2B1 TLN1 CPSF1 PYCR2 VCL | 1.18e-07 | 607 | 179 | 16 | 39147351 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNB HYOU1 ANK3 COPG1 VPS4A SPTAN1 FARSB COPG2 PSMD13 ECPAS PFN1 AP3B1 RUVBL2 MTAP AP1B1 AP2B1 TLN1 SVIL PYCR2 HSPA1L HCFC1 VCL | 1.32e-07 | 1149 | 179 | 22 | 35446349 |
| Pubmed | FLNB HYOU1 INTS7 NUP98 FARSB COPG2 PSMD13 BIRC6 PNPT1 OXCT1 AP1B1 AP2B1 CPSF1 PYCR2 ILKAP | 1.32e-07 | 534 | 179 | 15 | 35032548 | |
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 24555506 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 17404263 | ||
| Pubmed | Structural basis for regulation of protein phosphatase 1 by inhibitor-2. | 1.34e-07 | 3 | 179 | 3 | 17636256 | |
| Pubmed | Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages. | 1.34e-07 | 3 | 179 | 3 | 16034090 | |
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 15585880 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 19952892 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 10213096 | ||
| Pubmed | Talin and vinculin are downregulated in atherosclerotic plaque; Tampere Vascular Study. | 1.34e-07 | 3 | 179 | 3 | 27816808 | |
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 18508768 | ||
| Pubmed | Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion. | 1.34e-07 | 3 | 179 | 3 | 15494027 | |
| Pubmed | Vinculin controls talin engagement with the actomyosin machinery. | 1.34e-07 | 3 | 179 | 3 | 26634421 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 1.39e-07 | 10 | 179 | 4 | 22159418 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNB HYOU1 COPG1 DSG2 NUP98 PSMD13 MCCC1 PIR ECPAS PFN1 RAB6B RUVBL2 IKBIP OXCT1 MTAP AP1B1 FAM50A TLN1 PDCD11 HSPA1L HCFC1 MVD VCL ILKAP | 1.66e-07 | 1367 | 179 | 24 | 32687490 |
| Pubmed | FLNB HYOU1 ANK2 ANK3 DSG2 FARSB COPG2 ECPAS PFN1 AP3B1 RUVBL2 EFR3A GRIP1 TLN1 HCFC1 VCL EPHA3 | 1.75e-07 | 708 | 179 | 17 | 39231216 | |
| Pubmed | ANK2 COPG1 AUH DSG2 SPTAN1 FARSB SPECC1L PFN1 AP3B1 RUVBL2 DICER1 IKBIP PNPT1 AP1B1 AP2B1 CEBPZ FAM50A OSBPL3 TLN1 SVIL CPSF1 PDCD11 MED27 HCFC1 | 1.75e-07 | 1371 | 179 | 24 | 36244648 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | HYOU1 COPG1 DSG2 INTS7 VPS4A NUP98 FARSB COPG2 ECPAS AP3B1 PGM3 ATP2C1 AP1B1 CEBPZ TLN1 UTP20 FKBP8 HEATR5B PPP6R3 | 4.63e-07 | 942 | 179 | 19 | 31073040 |
| Pubmed | Chromosome localizations of genes for five cAMP-specific phosphodiesterases in man and mouse. | 4.68e-07 | 13 | 179 | 4 | 8009369 | |
| Pubmed | Cloning and characterization of human phosphatase inhibitor-2 (IPP-2) sequences. | 5.34e-07 | 4 | 179 | 3 | 7949733 | |
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 21670503 | ||
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 15644445 | ||
| Pubmed | Vinculin regulates assembly of talin: β3 integrin complexes. | 5.34e-07 | 4 | 179 | 3 | 24446374 | |
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 11839681 | ||
| Pubmed | DAB2IP FLNB FLT1 ANK2 INTS7 FRMD4A AP1B1 TENM3 SVIL MIOS BTRC PPP6R3 | 5.72e-07 | 371 | 179 | 12 | 15747579 | |
| Pubmed | FLNB HYOU1 MOGAT1 COPG1 DSG2 FN3KRP COPG2 PSMD13 ECPAS RUVBL2 AP1B1 AP2B1 TLN1 FKBP8 PYCR2 HEATR5B MVD PPP6R3 | 7.48e-07 | 878 | 179 | 18 | 37223481 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | COPG1 FARSB COPG2 AP3B1 RUVBL2 BIRC6 PGM3 DHX8 OXCT1 CEBPZ PDCD11 UTP20 PYCR2 DNAH8 HCFC1 ILKAP | 8.44e-07 | 704 | 179 | 16 | 29955894 |
| Pubmed | DAB2IP FLNB PDE4B HYOU1 ANK3 ARHGAP15 SMC6 FARSB COPG2 ZNF318 AP3B1 ADCY3 IKBIP TGFBR1 TGM4 TBC1D31 TMEM98 OSBPL3 VPS35L CPLANE1 | 9.07e-07 | 1084 | 179 | 20 | 11544199 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 9.50e-07 | 256 | 179 | 10 | 33397691 | |
| Pubmed | Protein Phosphatase-1 Inhibitor-2 Is a Novel Memory Suppressor. | 1.33e-06 | 5 | 179 | 3 | 26558779 | |
| Pubmed | Interaction between LIS1 and PDE4, and its role in cytoplasmic dynein function. | 1.33e-06 | 5 | 179 | 3 | 21652625 | |
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 30144392 | ||
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 28383060 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DAB2IP FLNB ANK3 DSG2 SPTAN1 COPG2 PFN1 EFR3A TENM3 TLN1 SVIL HCFC1 VCL UBFD1 | 1.55e-06 | 565 | 179 | 14 | 25468996 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNB HYOU1 DSG2 NUP98 ZNF318 SPECC1L PFN1 RUVBL2 DICER1 DHX8 ITPR2 CEBPZ TLN1 SVIL CPSF1 PDCD11 UTP20 FKBP8 HEATR5B | 1.59e-06 | 1024 | 179 | 19 | 24711643 |
| Pubmed | FLNB DRD5 HYOU1 ANK2 SPTA1 SPTAN1 NUP98 ZNF318 PEX11A PALB2 RYR2 CHRNB3 RUNDC3A MTAP TBC1D31 AP2B1 CEBPZ FAM50A RIMS1 TNFAIP8 PYCR2 HSPA1L DNAH8 | 1.59e-06 | 1442 | 179 | 23 | 35575683 | |
| Pubmed | FLNB COPG1 DSG2 SPTAN1 NUP98 COPG2 AP3B1 IKBIP PPP1R2B VPS13D TLN1 FKBP8 HCFC1 UBFD1 | 1.65e-06 | 568 | 179 | 14 | 37774976 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ANK2 DSG2 NUP98 FARSB COPG2 ZNF318 MCCC1 PFN1 PPP1R2B RBM12 AP2B1 FAM50A TLN1 HCFC1 VCL PPP6R3 UBFD1 ILKAP | 1.79e-06 | 934 | 179 | 18 | 33916271 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNB COPG1 VPS4A SPTAN1 FARSB PSMD13 MCCC1 PFN1 RUVBL2 BIRC6 GTF2H1 OXCT1 AP2B1 CEBPZ TLN1 CPSF1 PDCD11 UTP20 PYCR2 HSPA1L BTRC VCL | 2.01e-06 | 1353 | 179 | 22 | 29467282 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DAB2IP PDE4D ANK2 ANK3 SPTAN1 SPECC1L AP1B1 AP2B1 TLN2 RIMS1 | 2.19e-06 | 281 | 179 | 10 | 28706196 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNB HYOU1 DSG2 SPTAN1 NUP98 FARSB PSMD13 SPECC1L PFN1 RUVBL2 IKBIP AFAP1L1 DHX8 ITPR2 GTF2H1 AP2B1 CEBPZ SVIL CPSF1 PDCD11 UTP20 | 2.30e-06 | 1257 | 179 | 21 | 36526897 |
| Pubmed | 2.65e-06 | 6 | 179 | 3 | 23463619 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 2.65e-06 | 6 | 179 | 3 | 25966694 | |
| Pubmed | Mice carrying a complete deletion of the talin2 coding sequence are viable and fertile. | 2.65e-06 | 6 | 179 | 3 | 22925892 | |
| Pubmed | 2.65e-06 | 6 | 179 | 3 | 20519450 | ||
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 2.65e-06 | 6 | 179 | 3 | 23728480 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 2.65e-06 | 6 | 179 | 3 | 16844763 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 2.78e-06 | 168 | 179 | 8 | 30631154 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDE4C SPTAN1 NUP98 ZNF318 ECPAS ADARB1 PALB2 PPP1R2 KMT2D MTAP SVIL CPSF1 UTP20 TLN2 RIMS1 PPP6R3 | 2.86e-06 | 774 | 179 | 16 | 15302935 |
| Pubmed | 2.87e-06 | 226 | 179 | 9 | 31452512 | ||
| Pubmed | DSG2 INTS7 FARSB COPG2 ZNF318 SPECC1L AP3B1 RAB6B DICER1 DHX8 EFR3A GREB1L GTF2H1 CEBPZ TLN1 MIOS PDCD11 UTP20 FKBP8 HEATR5B MED27 THAP12 PPP6R3 | 2.97e-06 | 1497 | 179 | 23 | 31527615 | |
| Pubmed | ANK3 COPG1 DSG2 SMC6 NUP98 COPG2 ZNF318 SPECC1L MCCC1 PFN1 AP3B1 BIRC6 RYR2 ARFRP1 TENM3 FKBP8 | 3.00e-06 | 777 | 179 | 16 | 35844135 | |
| Pubmed | RARA RARB HYOU1 COPG1 NUP98 COPG2 RUVBL2 DHX8 FKBP8 HSPA1L HCFC1 | 3.20e-06 | 363 | 179 | 11 | 25036637 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNB HYOU1 COPG1 INTS7 SPTAN1 FN3KRP FARSB PSMD13 PFN1 AP3B1 RUVBL2 BIRC6 DHX8 PNPT1 MTAP AP1B1 AP2B1 CEBPZ FAM50A TLN1 HCFC1 PPP6R3 | 4.12e-06 | 1415 | 179 | 22 | 28515276 |
| Pubmed | 4.62e-06 | 7 | 179 | 3 | 11860456 | ||
| Pubmed | 4.62e-06 | 7 | 179 | 3 | 23266827 | ||
| Pubmed | Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. | 4.62e-06 | 7 | 179 | 3 | 7495297 | |
| Pubmed | Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality. | 4.62e-06 | 7 | 179 | 3 | 18689497 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 5.02e-06 | 182 | 179 | 8 | 31067453 | |
| Pubmed | 6.13e-06 | 187 | 179 | 8 | 26460568 | ||
| Pubmed | Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway. | 7.37e-06 | 8 | 179 | 3 | 28826662 | |
| Pubmed | Primary cilia are WNT-transducing organelles whose biogenesis is controlled by a WNT-PP1 axis. | 7.37e-06 | 8 | 179 | 3 | 36693320 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 7.37e-06 | 8 | 179 | 3 | 19033399 | |
| Pubmed | 7.37e-06 | 8 | 179 | 3 | 22017400 | ||
| Pubmed | SPTAN1 NUP98 FARSB COPG2 PSMD13 SPECC1L AP3B1 RUVBL2 DHX8 PPP1R2 PNPT1 AP2B1 CEBPZ TLN1 SVIL CPSF1 MED27 HCFC1 VCL PPP6R3 | 7.42e-06 | 1247 | 179 | 20 | 27684187 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | FLNB HYOU1 DSG2 SPTAN1 FARSB SPECC1L PFN1 DHX8 CEBPZ TLN1 HSPA1L VCL | 7.59e-06 | 477 | 179 | 12 | 31300519 |
| Pubmed | 7.89e-06 | 25 | 179 | 4 | 17307970 | ||
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 8.19e-06 | 139 | 179 | 7 | 25476789 | |
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 8.33e-06 | 195 | 179 | 8 | 17110338 | |
| Pubmed | HYOU1 ANK2 ANK3 DSG2 SPTAN1 PSMD13 AP3B1 DICER1 IKBIP ITPR2 EFR3A WDR19 PNPT1 TBC1D31 CEBPZ TLN1 PDCD11 FKBP8 PYCR2 HSPA1L VCL PPP6R3 | 8.99e-06 | 1487 | 179 | 22 | 33957083 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | HYOU1 DSG2 MCCC1 ECPAS RUVBL2 TAB3 PPP1R2 GRIP1 MTAP TBC1D31 OSBPL3 TLN1 SVIL CPLANE1 VCL PPP6R3 | 9.67e-06 | 853 | 179 | 16 | 28718761 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | FLNB HYOU1 COPG1 FARSB COPG2 PSMD13 AP3B1 RUVBL2 OXCT1 AP1B1 AP2B1 PYCR2 HSPA1L HCFC1 | 9.96e-06 | 665 | 179 | 14 | 30457570 |
| Pubmed | 1.10e-05 | 9 | 179 | 3 | 20877300 | ||
| Pubmed | 1.10e-05 | 9 | 179 | 3 | 11807098 | ||
| Pubmed | DAB2IP PDE4A PDE4B ANK2 ANK3 SPTAN1 FARSB ZNF318 SPECC1L AP1B1 AP2B1 OSBPL3 SVIL MIOS TLN2 RIMS1 WNK2 | 1.11e-05 | 963 | 179 | 17 | 28671696 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NUGGC DPYD FLT1 ANK3 PSMD13 ECPAS RYR3 SNX14 VPS13D CPSF1 FKBP8 HCFC1 | 1.14e-05 | 497 | 179 | 12 | 36774506 |
| Interaction | SIRT7 interactions | FLNB HYOU1 COPG1 SPTAN1 NUP98 COPG2 ZNF318 ECPAS BIRC6 DICER1 DHX8 PNPT1 AP1B1 AP2B1 CEBPZ TLN1 CPSF1 PDCD11 UTP20 HCFC1 VCL PPP6R3 | 4.88e-07 | 744 | 174 | 22 | int:SIRT7 |
| Interaction | WWTR1 interactions | ANK3 DSG2 SPTAN1 ZNF318 SPECC1L AP3B1 RUVBL2 TAB3 KMT2D CEBPZ TLN1 PDCD11 HCFC1 BTRC PPP6R3 | 4.10e-06 | 422 | 174 | 15 | int:WWTR1 |
| Interaction | AAK1 interactions | 1.03e-05 | 121 | 174 | 8 | int:AAK1 | |
| Interaction | AGR2 interactions | FLNB HYOU1 ANK3 COPG1 SPTA1 SPTAN1 COPG2 PSMD13 MCCC1 PIR ECPAS PFN1 AP3B1 RUVBL2 MTAP AP1B1 AP2B1 TLN1 HSPA1L MYO16 MVD VCL | 1.89e-05 | 934 | 174 | 22 | int:AGR2 |
| Interaction | KIF13A interactions | 2.33e-05 | 40 | 174 | 5 | int:KIF13A | |
| Interaction | SLFN11 interactions | FLNB SPTAN1 NUP98 SREBF1 SPECC1L AP3B1 RUVBL2 PALB2 DHX8 GTF2H1 CEBPZ CPSF1 VCL | 2.45e-05 | 376 | 174 | 13 | int:SLFN11 |
| Interaction | PHLPP1 interactions | FLNB DSG2 SPTAN1 NUP98 COPG2 ZNF318 PSMD13 PFN1 EFR3A TLN1 HCFC1 BTRC | 3.40e-05 | 333 | 174 | 12 | int:PHLPP1 |
| Interaction | BUB1B interactions | 5.11e-05 | 195 | 174 | 9 | int:BUB1B | |
| Interaction | SRI interactions | 5.83e-05 | 78 | 174 | 6 | int:SRI | |
| Interaction | KCTD13 interactions | FLNB PDE4D HYOU1 ANK2 ANK3 SPTA1 SPTAN1 RBP3 FARSB SPECC1L PFN1 AP3B1 PNMA8B ITPR2 CRYM AP1B1 AP2B1 TLN1 SVIL MIOS TLN2 RIMS1 PYCR2 HSPA1L WNK2 VCL CACNA2D3 | 6.41e-05 | 1394 | 174 | 27 | int:KCTD13 |
| Interaction | KCNA3 interactions | FLNB HYOU1 ANK2 ANK3 DSG2 FARSB COPG2 SPECC1L ECPAS PFN1 AP3B1 RUVBL2 EFR3A GRIP1 TLN1 TLN2 RIMS1 HCFC1 VCL EPHA3 | 6.62e-05 | 871 | 174 | 20 | int:KCNA3 |
| GeneFamily | Phosphodiesterases | 1.50e-05 | 24 | 115 | 4 | 681 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.20e-04 | 3 | 115 | 2 | 287 | |
| GeneFamily | Perilipins | 3.96e-04 | 5 | 115 | 2 | 678 | |
| GeneFamily | Calcium voltage-gated channel subunits | 5.86e-04 | 26 | 115 | 3 | 253 | |
| GeneFamily | EF-hand domain containing|Spectrins | 8.25e-04 | 7 | 115 | 2 | 1113 | |
| GeneFamily | Transglutaminases | 1.40e-03 | 9 | 115 | 2 | 773 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | TDRD5 RBM44 PEX11A BIRC6 CDC14A AK7 RYR2 BFSP1 ZNF518A PNMA8B ITPR2 GREB1L HEG1 PLXNC1 RIMS1 CPLANE1 DNAH8 BTRC | 6.51e-05 | 770 | 174 | 18 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | TDRD5 RBM44 BIRC6 AK7 RYR2 BFSP1 PNMA8B GREB1L HEG1 PLXNC1 CPLANE1 DNAH8 | 7.18e-05 | 379 | 174 | 12 | gudmap_developingGonad_P2_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | RBM44 SMC6 ZNF318 ECPAS BIRC6 ADARB1 CDC14A AK7 PALB2 RYR2 ZNF518A PNMA8B GREB1L TMEM130 HEG1 CPLANE1 DNAH8 BTRC | 7.19e-05 | 776 | 174 | 18 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | TDRD5 RBM44 ZNF318 BIRC6 AK7 RYR2 PNMA8B GREB1L HEG1 PLXNC1 CPLANE1 BTRC | 8.75e-05 | 387 | 174 | 12 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | TDRD5 RBM44 SPTA1 ZNF318 PEX11A BIRC6 CDC14A AK7 RYR2 PNMA8B ITPR2 GREB1L HEG1 SEMA6D PLXNC1 CPLANE1 DNAH8 BTRC | 9.75e-05 | 795 | 174 | 18 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_500 | 1.04e-04 | 91 | 174 | 6 | gudmap_developingGonad_e14.5_ ovary_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.18e-04 | 179 | 174 | 8 | gudmap_developingGonad_e14.5_ ovary_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | PDE4D RARB DSG2 SMC6 SLC26A5 REN ECPAS AP3B1 EFR3A TGFBR1 PPP1R2B CRYM ATP2C1 TBC1D31 TMEM98 ZNF624 TNFAIP8 HEATR5B ST18 PPP6R3 | 1.82e-04 | 989 | 174 | 20 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.90e-04 | 192 | 174 | 8 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.94e-04 | 65 | 174 | 5 | gudmap_developingGonad_e12.5_epididymis_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 2.04e-04 | 194 | 174 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | TDRD5 RBM44 ZNF318 PEX11A BIRC6 CDC14A AK7 RYR2 ZNF518A PNMA8B ITPR2 GREB1L TMEM130 HEG1 PLXNC1 CPLANE1 BTRC | 2.33e-04 | 778 | 174 | 17 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.35e-04 | 251 | 174 | 9 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | SMC6 AP3B1 DICER1 ZNF518A WDR19 HEG1 OXCT1 MTAP CEBPZ ZNF624 | 2.56e-04 | 311 | 174 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | MXRA5 ANK2 RYR2 RYR3 TMEM130 CRYM SEMA6D TENM3 SVIL CACNA2D3 | 4.05e-09 | 185 | 178 | 10 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.72e-08 | 187 | 178 | 9 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.92e-07 | 184 | 178 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.92e-07 | 184 | 178 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.92e-07 | 184 | 178 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 9.31e-07 | 188 | 178 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-07 | 189 | 178 | 8 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-07 | 189 | 178 | 8 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-07 | 189 | 178 | 8 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-06 | 132 | 178 | 7 | 46c80eab16a70da9f363a9fbdf50bccab0b287d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-06 | 132 | 178 | 7 | a022c3c41654166cb106f27dc54fa88e8c40f898 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.05e-06 | 191 | 178 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-06 | 192 | 178 | 8 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 193 | 178 | 8 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-06 | 198 | 178 | 8 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.62e-06 | 159 | 178 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 7.33e-06 | 177 | 178 | 7 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 7.33e-06 | 177 | 178 | 7 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-06 | 179 | 178 | 7 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.12e-06 | 183 | 178 | 7 | c7e94fe3e7669db9304b249979fef7a69c30a143 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.09e-05 | 188 | 178 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.09e-05 | 188 | 178 | 7 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.12e-05 | 189 | 178 | 7 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 189 | 178 | 7 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-VLMC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-05 | 190 | 178 | 7 | c90410bb47b8da774dee2a3502f667ce9a7c97d9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-05 | 190 | 178 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-VLMC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-05 | 190 | 178 | 7 | bc44727e8458a02fae95dc5515b708000d2ee8c4 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.20e-05 | 191 | 178 | 7 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.20e-05 | 191 | 178 | 7 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.20e-05 | 191 | 178 | 7 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 192 | 178 | 7 | 0b9b2eaed45456d7d74ce78a64ef4a26ac2458fb | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.29e-05 | 193 | 178 | 7 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.29e-05 | 193 | 178 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 193 | 178 | 7 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 194 | 178 | 7 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 194 | 178 | 7 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.33e-05 | 194 | 178 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.33e-05 | 194 | 178 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.42e-05 | 196 | 178 | 7 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 197 | 178 | 7 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 197 | 178 | 7 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-05 | 197 | 178 | 7 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-05 | 198 | 178 | 7 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.57e-05 | 199 | 178 | 7 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-05 | 199 | 178 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.57e-05 | 199 | 178 | 7 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.57e-05 | 199 | 178 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-05 | 144 | 178 | 6 | 5665dd2839b6c8ddbf5ddb2d22e1ee6073f74c3b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 155 | 178 | 6 | 59035d792c26d870a8b097939e97fa47859ba68c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 160 | 178 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 160 | 178 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-05 | 162 | 178 | 6 | c399b9e4854916a59f5cae2d8dbf19660f8759be | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-05 | 162 | 178 | 6 | a291248b693c771845174393934a782f1d8bd7ce | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.73e-05 | 167 | 178 | 6 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.73e-05 | 167 | 178 | 6 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.73e-05 | 167 | 178 | 6 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 171 | 178 | 6 | 2e7cc311005958af52f39ca6c310c85b43a85aaf | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.53e-05 | 171 | 178 | 6 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.53e-05 | 171 | 178 | 6 | bdd30100b74e012eec3090799c22635aa57fa91d | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 171 | 178 | 6 | 4b599f953c8e5b947b2c8bbbf7fe6f9dc388e336 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.53e-05 | 171 | 178 | 6 | b7cddb8f726a43fb8a37f3e67a3f722e2178fd7a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.74e-05 | 172 | 178 | 6 | 18bdf34e1b94dcb1daf00c533e3ce1a8d67fcc0e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.74e-05 | 172 | 178 | 6 | 41ddfb316429efef5f3fa0b0621ced383d9206f0 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.96e-05 | 173 | 178 | 6 | ec88e871b49331fca59bc610a8ae58e2d5e76bc1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.96e-05 | 173 | 178 | 6 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.96e-05 | 173 | 178 | 6 | 22200fe74e33e2beae0eed289ca8476bbc0b1b2d | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-05 | 175 | 178 | 6 | 91cb819a1786020713b7e64480de0545380daae9 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 176 | 178 | 6 | 2e9073166da4d9fae70ba4f3fdcad35523caf7cd | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 7.66e-05 | 176 | 178 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.90e-05 | 177 | 178 | 6 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 177 | 178 | 6 | c6812679aa6522d03bd29144e71c5fae6a92325e | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 7.90e-05 | 177 | 178 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 177 | 178 | 6 | ff97398d2adb83063b7c53a264bfae86ea7ea304 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.90e-05 | 177 | 178 | 6 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.90e-05 | 177 | 178 | 6 | b6476a91abd06b8271b4d0ad7431d24b44022b47 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.90e-05 | 177 | 178 | 6 | 0e74980a7686c31fcf1476b8f19a3392541df240 | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 8.15e-05 | 178 | 178 | 6 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-VLMC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.40e-05 | 179 | 178 | 6 | 381ac15d59f31bc613828bdcfbc9192b106b4d18 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.40e-05 | 179 | 178 | 6 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 8.66e-05 | 180 | 178 | 6 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 8.93e-05 | 181 | 178 | 6 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.93e-05 | 181 | 178 | 6 | ee207ea171e2ffc22a7f850be57bb118a87e0f81 | |
| ToppCell | facs-Thymus-Epithelium-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-05 | 181 | 178 | 6 | bce56e12ab93693c9c04fa6aad8f2e1dff0c4d45 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 9.49e-05 | 183 | 178 | 6 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.49e-05 | 183 | 178 | 6 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 9.49e-05 | 183 | 178 | 6 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 9.49e-05 | 183 | 178 | 6 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Slc17a8|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.72e-05 | 60 | 178 | 4 | 40f29dfdbb17d39d8e6bb69dc5066fca3cd03308 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Slc17a8-Inhibitory_Neuron.Gad1Gad2Slc17a8_Sst.Ncam2_(Interneuron,__GABA/Glutamate_co-releasing?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.72e-05 | 60 | 178 | 4 | 3a58f7a8e3d8a544286b7a3fe62efac8a0a0bb11 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Slc17a8-Inhibitory_Neuron.Gad1Gad2Slc17a8_Sst.Ncam2_(Interneuron,__GABA/Glutamate_co-releasing?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.72e-05 | 60 | 178 | 4 | ce13bbda7d105e1cb421790fb50d3b55ba2ed09a | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 9.78e-05 | 184 | 178 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 185 | 178 | 6 | 742350093d90f96735dc73e3360cdd749bae63fd | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 185 | 178 | 6 | 62cfcb0e2a9e6718e6b200dfbb1a81eaead229b5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 185 | 178 | 6 | a0a629e5d2b65f670ea907bd3f5e3caf17687d8f | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.01e-04 | 185 | 178 | 6 | e9059cefcdf0972ec90793b1dd34c3292b17a061 | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 1.01e-04 | 185 | 178 | 6 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 186 | 178 | 6 | e3a14f3ccadbf3211822c67b8956ee01f563307a | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 186 | 178 | 6 | 75258d88e23112fd1f0f7c71ef0366abb400d33e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 186 | 178 | 6 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.04e-04 | 186 | 178 | 6 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| Drug | Piclamilast | 3.61e-09 | 4 | 178 | 4 | DB01791 | |
| Drug | Ibudilast | 1.80e-08 | 5 | 178 | 4 | DB05266 | |
| Drug | 1,7-naphthyridine | 1.80e-08 | 5 | 178 | 4 | CID000009209 | |
| Drug | Ketotifen | 1.24e-07 | 7 | 178 | 4 | DB00920 | |
| Drug | Iloprost | 1.24e-07 | 7 | 178 | 4 | DB01088 | |
| Drug | papaverine | CACNA1S PDE4A PDE4B PDE4C PDE4D CACNA2D2 REN ADCY3 RYR2 RYR3 CACNA2D3 | 1.47e-07 | 176 | 178 | 11 | CID000004680 |
| Drug | Dyphylline | 2.47e-07 | 8 | 178 | 4 | DB00651 | |
| Drug | trequinsin | 4.41e-07 | 9 | 178 | 4 | ctd:C035964 | |
| Drug | L-826,141 | 4.41e-07 | 9 | 178 | 4 | ctd:C459562 | |
| Drug | 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid | 4.70e-07 | 3 | 178 | 3 | DB08299 | |
| Drug | NVP ABE171 | 7.31e-07 | 10 | 178 | 4 | ctd:C451724 | |
| Drug | felodipine | CACNA1S PDE4A PDE4B PDE4C PDE4D CACNA2D2 REN RYR2 RYR3 CACNA2D3 | 9.06e-07 | 169 | 178 | 10 | CID000003333 |
| Drug | arabinosyladenine | PDE4A PDE4B PDE4C PDE4D DRD5 CACNA2D2 SPTA1 FARSB REN ADARB1 F8 ADCY3 AK7 RYR2 RYR3 PNPT1 ATP2C1 MTAP TNFAIP8 THAP12 | 2.34e-06 | 762 | 178 | 20 | CID000000191 |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 2.86e-06 | 79 | 178 | 7 | CID005287890 | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; MCF7; HT_HG-U133A | CACNA2D2 DICER1 BFSP1 ITPR2 COMMD4 TLN1 NIPAL2 FKBP8 HSD17B14 HCFC1 | 3.15e-06 | 194 | 178 | 10 | 3273_DN |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A | RARB ECPAS CDC14A ADCY3 VPS13D HEG1 ARFRP1 FKBP8 HCFC1 EPHA3 | 3.78e-06 | 198 | 178 | 10 | 5684_DN |
| Drug | D-22888 | 4.64e-06 | 5 | 178 | 3 | CID000197714 | |
| Drug | Cinildipine | 4.93e-06 | 56 | 178 | 6 | CID000002752 | |
| Drug | CNS 1145 | 5.49e-06 | 33 | 178 | 5 | CID000190902 | |
| Drug | IHC-64 | 5.49e-06 | 33 | 178 | 5 | CID000162753 | |
| Drug | Roflumilast | 6.11e-06 | 16 | 178 | 4 | ctd:C424423 | |
| Drug | nilvadipine | 7.40e-06 | 60 | 178 | 6 | CID000004494 | |
| Drug | chloro-m-cresol | 9.24e-06 | 6 | 178 | 3 | CID000012008 | |
| Drug | NSC114784 | 9.24e-06 | 6 | 178 | 3 | CID000419425 | |
| Drug | caffeine | CACNA1S PDE4A PDE4B PDE4C PDE4D DRD5 CACNA2D2 REN ADCY3 RYR2 CHRNB3 RYR3 ATP2C1 TNFAIP8 VCL CACNA2D3 | 9.36e-06 | 562 | 178 | 16 | CID000002519 |
| Drug | Cilomilast | 1.01e-05 | 18 | 178 | 4 | ctd:C433247 | |
| Drug | lanthanum | 1.20e-05 | 136 | 178 | 8 | CID000023926 | |
| Drug | gallopamil | 1.41e-05 | 67 | 178 | 6 | CID000001234 | |
| Drug | zaprinast | 1.56e-05 | 141 | 178 | 8 | CID000005722 | |
| Drug | AC1L2AC7 | 1.67e-05 | 69 | 178 | 6 | CID000068733 | |
| Drug | AA-2379 | 1.95e-05 | 21 | 178 | 4 | CID000128390 | |
| Drug | NSC759576 | 2.03e-05 | 191 | 178 | 9 | CID000003075 | |
| Drug | Betamethasone [378-44-9]; Up 200; 10.2uM; PC3; HT_HG-U133A | CACNA2D2 SPTAN1 POM121L2 ITPR2 TGFBR1 RUNDC3A COMMD4 MIOS MVD | 2.11e-05 | 192 | 178 | 9 | 6728_UP |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.30e-05 | 194 | 178 | 9 | 4727_DN | |
| Drug | CAS 298-57-7 | 2.31e-05 | 73 | 178 | 6 | CID000002761 | |
| Drug | HWA 153 | 2.37e-05 | 22 | 178 | 4 | CID000162797 | |
| Drug | Bay K 8644 | 2.44e-05 | 150 | 178 | 8 | CID000002303 | |
| Drug | 2-naphthoic acid | 2.56e-05 | 8 | 178 | 3 | CID000007123 | |
| Drug | KF18280 | 2.56e-05 | 8 | 178 | 3 | CID003071941 | |
| Drug | Carbimazole [22232-54-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 2.59e-05 | 197 | 178 | 9 | 3299_UP | |
| Drug | Isometheptene mucate; Up 200; 8.2uM; PC3; HT_HG-U133A | 2.59e-05 | 197 | 178 | 9 | 5082_UP | |
| Drug | Monocrotaline [315-22-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.59e-05 | 197 | 178 | 9 | 2749_UP | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; HL60; HT_HG-U133A | 2.70e-05 | 198 | 178 | 9 | 2200_DN | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Up 200; 9.8uM; PC3; HT_HG-U133A | 2.70e-05 | 198 | 178 | 9 | 4609_UP | |
| Drug | Nabumetone [42924-53-8]; Up 200; 17.6uM; PC3; HT_HG-U133A | 2.70e-05 | 198 | 178 | 9 | 6327_UP | |
| Drug | griseolic acid | 2.85e-05 | 23 | 178 | 4 | CID000127607 | |
| Drug | atherosperminine | 2.85e-05 | 23 | 178 | 4 | CID000096918 | |
| Drug | nisoldipine | 3.38e-05 | 78 | 178 | 6 | CID000004499 | |
| Drug | AC1LD7MJ | 3.98e-05 | 49 | 178 | 5 | CID000643628 | |
| Drug | cilostamide | 4.49e-05 | 120 | 178 | 7 | CID000002753 | |
| Drug | desethyl KBT-3022 | 4.72e-05 | 26 | 178 | 4 | CID000127736 | |
| Drug | T-440 | 4.72e-05 | 26 | 178 | 4 | CID000177965 | |
| Drug | Ro 15-2041 | 4.72e-05 | 26 | 178 | 4 | CID000132434 | |
| Drug | apocarotenal | 4.81e-05 | 83 | 178 | 6 | ctd:C004984 | |
| Drug | geldanamycin; Up 200; 1uM; HL60; HT_HG-U133A | 5.25e-05 | 167 | 178 | 8 | 6187_UP | |
| Drug | V11294 Analogue 5f | 6.08e-05 | 2 | 178 | 2 | CID011214587 | |
| Drug | V11294 Analogue 5t | 6.08e-05 | 2 | 178 | 2 | CID011226695 | |
| Drug | V11294 Analogue 5e | 6.08e-05 | 2 | 178 | 2 | CID011443441 | |
| Drug | Ro 8-8717 | 6.08e-05 | 2 | 178 | 2 | CID006438148 | |
| Drug | V11294 Analogue 5n | 6.08e-05 | 2 | 178 | 2 | CID011238279 | |
| Drug | V11294 Analogue 5p | 6.08e-05 | 2 | 178 | 2 | CID011478659 | |
| Drug | V11294 Analogue 5o | 6.08e-05 | 2 | 178 | 2 | CID011249748 | |
| Drug | V11294 Analogue 5c | 6.08e-05 | 2 | 178 | 2 | CID011179896 | |
| Drug | V11294 Analogue 5b | 6.08e-05 | 2 | 178 | 2 | CID011443760 | |
| Drug | Cis-4-Cyano-4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]Cyclohexanecarboxylic Acid | 6.08e-05 | 2 | 178 | 2 | DB03849 | |
| Drug | T-2585.HCl | 6.08e-05 | 2 | 178 | 2 | CID006918355 | |
| Drug | V11294 Analogue 5m | 6.08e-05 | 2 | 178 | 2 | CID011477773 | |
| Drug | V11294 Analogue 8a | 6.08e-05 | 2 | 178 | 2 | CID011442865 | |
| Drug | U138 | 6.08e-05 | 2 | 178 | 2 | CID000006681 | |
| Drug | V11294 Analogue 5q | 6.08e-05 | 2 | 178 | 2 | CID011318772 | |
| Drug | V11294 Analogue 5h | 6.08e-05 | 2 | 178 | 2 | CID011306698 | |
| Drug | 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester | 6.08e-05 | 2 | 178 | 2 | DB01959 | |
| Drug | 4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]-2-Pyrrolidinone | 6.08e-05 | 2 | 178 | 2 | DB01954 | |
| Drug | M 98 | 6.08e-05 | 2 | 178 | 2 | CID006420180 | |
| Drug | V11294 Analogue 5i | 6.08e-05 | 2 | 178 | 2 | CID011376249 | |
| Drug | V11294 Analogue 5d | 6.08e-05 | 2 | 178 | 2 | CID011283750 | |
| Drug | 3-cyclopentyloxy-4-methoxybenzoic acid | 6.08e-05 | 2 | 178 | 2 | CID002779323 | |
| Drug | V11294 Analogue 5v | 6.08e-05 | 2 | 178 | 2 | CID011375325 | |
| Drug | 3-cyclopentyloxy-4-methoxybenzaldehyde | 6.08e-05 | 2 | 178 | 2 | CID002735893 | |
| Drug | Np-V | 6.08e-05 | 2 | 178 | 2 | CID009999276 | |
| Drug | Tamibarotene | 6.08e-05 | 2 | 178 | 2 | DB04942 | |
| Drug | (S)-Rolipram | 6.08e-05 | 2 | 178 | 2 | DB03606 | |
| Drug | 1-((5-(1-aminoethyl)-2-(8-methoxy-2-(triflurormethyl)-5-quinolinyl)-4-oxazolyl) carbonyl)-4-((cyclopropylcarbonyl)amino)proline ethyl ester | 6.08e-05 | 2 | 178 | 2 | ctd:C554440 | |
| Drug | V11294 Analogue 5r | 6.08e-05 | 2 | 178 | 2 | CID011168555 | |
| Drug | V11294 Analogue 5j | 6.08e-05 | 2 | 178 | 2 | CID011433797 | |
| Drug | V11294 Analogue 5a | 6.08e-05 | 2 | 178 | 2 | CID011386897 | |
| Drug | V11294 Analogue 5k | 6.08e-05 | 2 | 178 | 2 | CID011456440 | |
| Drug | (R)-Rolipram | 6.08e-05 | 2 | 178 | 2 | DB04149 | |
| Drug | (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one | 6.08e-05 | 2 | 178 | 2 | DB06842 | |
| Drug | AC1O3R20 | 6.39e-05 | 28 | 178 | 4 | CID006335051 | |
| Drug | motapizone | 7.36e-05 | 29 | 178 | 4 | CID000065819 | |
| Drug | R 478 | 7.40e-05 | 11 | 178 | 3 | CID000084223 | |
| Drug | manidipine | 1.03e-04 | 95 | 178 | 6 | CID000004008 | |
| Drug | imidazole-4-carboxamide | 1.09e-04 | 32 | 178 | 4 | CID000152917 | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; PC3; HT_HG-U133A | 1.12e-04 | 186 | 178 | 8 | 4271_UP | |
| Drug | IAA-94 | 1.15e-04 | 61 | 178 | 5 | CID000003667 | |
| Drug | nitrendipine | 1.22e-04 | 98 | 178 | 6 | CID000004507 | |
| Drug | dyphylline | 1.24e-04 | 33 | 178 | 4 | CID000003182 | |
| Drug | lercanidipine | 1.34e-04 | 63 | 178 | 5 | CID000065866 | |
| Drug | isradipine | 1.36e-04 | 100 | 178 | 6 | CID000003784 | |
| Disease | chronotype measurement | DPYD PDE4B RARB ANK2 ANK3 ARHGAP15 CACNA2D2 SLC26A5 ZNF318 RFTN2 BIRC6 ADCY3 KMT2D SEMA6D AP2B1 RASD1 RIMS1 ST18 MYO16 | 1.39e-06 | 882 | 175 | 19 | EFO_0008328 |
| Disease | Osteoporosis | 3.69e-05 | 63 | 175 | 5 | C0029456 | |
| Disease | Manic | 1.03e-04 | 78 | 175 | 5 | C0338831 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.05e-04 | 3 | 175 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.05e-04 | 3 | 175 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | cognitive function measurement | DPYD PDE4D MOGAT1 ARHGAP15 CACNA2D2 TMEM161B SLC35B3 POM121L2 COPG2 BIRC6 GALNT18 RYR3 EFR3A WDR19 FRMD4A KMT2D SEMA6D AP1B1 MED27 WNK2 CACNA2D3 | 1.26e-04 | 1434 | 175 | 21 | EFO_0008354 |
| Disease | Tinnitus | 1.30e-04 | 130 | 175 | 6 | HP_0000360 | |
| Disease | Bipolar Disorder | PDE4A PDE4B DRD5 ANK3 REN ADARB1 ADCY3 PALB2 CHRNB3 RIMS1 DNAH8 | 1.40e-04 | 477 | 175 | 11 | C0005586 |
| Disease | Neuralgia-Neuritis, Sciatic Nerve | 2.08e-04 | 4 | 175 | 2 | C0751924 | |
| Disease | Sciatic Nerve Palsy | 2.08e-04 | 4 | 175 | 2 | C0751925 | |
| Disease | Sciatic Neuropathy | 2.08e-04 | 4 | 175 | 2 | C0149940 | |
| Disease | Lesion of Sciatic Nerve | 2.08e-04 | 4 | 175 | 2 | C0154748 | |
| Disease | Sciatic Neuritis | 2.08e-04 | 4 | 175 | 2 | C0242013 | |
| Disease | response to steroid, systemic lupus erythematosus, idiopathic osteonecrosis of the femoral head | 2.08e-04 | 4 | 175 | 2 | EFO_0020976, EFO_1001930, MONDO_0007915 | |
| Disease | preeclampsia, fetal genotype effect measurement | 3.46e-04 | 5 | 175 | 2 | EFO_0000668, EFO_0007959 | |
| Disease | Malignant Cystosarcoma Phyllodes | 3.46e-04 | 5 | 175 | 2 | C0600066 | |
| Disease | pack-years measurement, Barrett's esophagus | 3.46e-04 | 5 | 175 | 2 | EFO_0000280, EFO_0006526 | |
| Disease | Phyllodes Tumor | 3.46e-04 | 5 | 175 | 2 | C0010701 | |
| Disease | Post-Traumatic Osteoporosis | 4.79e-04 | 61 | 175 | 4 | C0751406 | |
| Disease | Osteoporosis, Senile | 4.79e-04 | 61 | 175 | 4 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 4.79e-04 | 61 | 175 | 4 | C0001787 | |
| Disease | response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema | 4.82e-04 | 26 | 175 | 3 | EFO_0005325, EFO_0005532, EFO_0010735 | |
| Disease | age at diagnosis, substance-related disorder | 5.16e-04 | 6 | 175 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | clubfoot (implicated_via_orthology) | 5.16e-04 | 6 | 175 | 2 | DOID:11836 (implicated_via_orthology) | |
| Disease | smoking status measurement | DPYD PDE4B RARB ARHGAP15 BIRC6 ADARB1 ADCY3 RYR2 ZNF518A ATP2C1 SEMA6D OR10A6 RIMS1 FKBP8 MED27 DNAH8 BTRC | 5.68e-04 | 1160 | 175 | 17 | EFO_0006527 |
| Disease | wheezing | 6.10e-04 | 65 | 175 | 4 | EFO_0009715 | |
| Disease | refractive error | 7.68e-04 | 326 | 175 | 8 | MONDO_0004892 | |
| Disease | chin morphology measurement | 8.08e-04 | 70 | 175 | 4 | EFO_0007842 | |
| Disease | peak expiratory flow | RARB ANK3 ARHGAP15 ZC3H12B AFAP1L1 PNPT1 SVIL TNFAIP8 CACNA2D3 PPP6R3 | 8.23e-04 | 498 | 175 | 10 | EFO_0009718 |
| Disease | Manic Disorder | 8.52e-04 | 71 | 175 | 4 | C0024713 | |
| Disease | psychotic symptoms | 9.95e-04 | 74 | 175 | 4 | EFO_0005940 | |
| Disease | refractive error, age at onset, Myopia | 1.06e-03 | 193 | 175 | 6 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | cup-to-disc ratio measurement | 1.12e-03 | 430 | 175 | 9 | EFO_0006939 | |
| Disease | Depression, Bipolar | 1.27e-03 | 79 | 175 | 4 | C0005587 | |
| Disease | cigarettes per day measurement | 1.27e-03 | 438 | 175 | 9 | EFO_0006525 | |
| Disease | orofacial cleft | 1.37e-03 | 37 | 175 | 3 | MONDO_0000358 | |
| Disease | sleep duration | 1.50e-03 | 362 | 175 | 8 | EFO_0005271 | |
| Disease | response to hydrochlorothiazide, diastolic blood pressure change measurement | 1.53e-03 | 10 | 175 | 2 | EFO_0005202, EFO_0006945 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 1.53e-03 | 10 | 175 | 2 | C1631597 | |
| Disease | Microphthalmos | 1.86e-03 | 11 | 175 | 2 | C0026010 | |
| Disease | schizophrenia, gastroesophageal reflux disease | 1.86e-03 | 11 | 175 | 2 | EFO_0003948, MONDO_0005090 | |
| Disease | Malignant neoplasm of breast | FLNB DPYD FLT1 ABCA4 RARA RARB ANK2 SPTAN1 SMC6 NUP98 ZNF318 PALB2 KMT2D ARFRP1 UTP20 | 1.92e-03 | 1074 | 175 | 15 | C0006142 |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma | 1.99e-03 | 42 | 175 | 3 | EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354 | |
| Disease | Oligospermia | 2.22e-03 | 12 | 175 | 2 | C0028960 | |
| Disease | Alcohol Use Disorder | 2.27e-03 | 44 | 175 | 3 | C0001956 | |
| Disease | diastolic blood pressure, systolic blood pressure | FLT1 PDE4D ANK2 ANK3 ARHGAP15 RYR2 PNPT1 PLXNC1 SVIL TLN2 BTRC | 2.28e-03 | 670 | 175 | 11 | EFO_0006335, EFO_0006336 |
| Disease | Alzheimer disease | 2.54e-03 | 485 | 175 | 9 | MONDO_0004975 | |
| Disease | hearing impairment | 2.80e-03 | 98 | 175 | 4 | C1384666 | |
| Disease | vital capacity | CACNA1S FLT1 ADAMTSL1 RARB CACNA2D2 POM121L2 MCCC1 AP3B1 ADCY3 RYR2 AFAP1L1 PNPT1 TNFAIP8 MYO16 CACNA2D3 EPHA3 | 2.91e-03 | 1236 | 175 | 16 | EFO_0004312 |
| Disease | trimethylamine-N-oxide measurement | 3.04e-03 | 14 | 175 | 2 | EFO_0010541 | |
| Disease | Psychosis, Brief Reactive | 3.04e-03 | 14 | 175 | 2 | C0033958 | |
| Disease | Schizophreniform Disorders | 3.04e-03 | 14 | 175 | 2 | C0036358 | |
| Disease | Psychotic Disorders | 3.12e-03 | 101 | 175 | 4 | C0033975 | |
| Disease | smoking cessation | 3.38e-03 | 325 | 175 | 7 | EFO_0004319 | |
| Disease | Uveal Melanoma | 3.86e-03 | 53 | 175 | 3 | EFO_1000616 | |
| Disease | response to cisplatin, platinum measurement | 3.86e-03 | 53 | 175 | 3 | EFO_0010154, GO_0072718 | |
| Disease | abdominal adipose tissue measurement | 3.86e-03 | 53 | 175 | 3 | EFO_0803316 | |
| Disease | resting metabolic rate measurement | 3.97e-03 | 16 | 175 | 2 | EFO_0008004 | |
| Disease | N-acetyl-beta-alanine measurement | 3.97e-03 | 16 | 175 | 2 | EFO_0021430 | |
| Disease | hair morphology measurement | 4.07e-03 | 54 | 175 | 3 | EFO_0007821 | |
| Disease | attempted suicide | 4.28e-03 | 178 | 175 | 5 | EFO_0004321 | |
| Disease | Uremia | 4.49e-03 | 17 | 175 | 2 | C0041948 | |
| Disease | pneumonia, COVID-19 | 4.66e-03 | 113 | 175 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | coffee consumption measurement | 4.69e-03 | 182 | 175 | 5 | EFO_0006781 | |
| Disease | Hypermetropia, Myopia | 5.50e-03 | 189 | 175 | 5 | HP_0000540, HP_0000545 | |
| Disease | age at onset, smoking initiation | 5.60e-03 | 19 | 175 | 2 | EFO_0004847, EFO_0005670 | |
| Disease | coronary artery calcification | 5.60e-03 | 450 | 175 | 8 | EFO_0004723 | |
| Disease | diffuse plaque measurement | ADAMTSL1 PDE4B ANK2 ARHGAP15 GALNT18 ITPR2 FRMD4A SEMA6D PLXNC1 MYO16 CACNA2D3 | 5.75e-03 | 758 | 175 | 11 | EFO_0010699 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TRAGSLLMLKKSVTE | 191 | Q8NAT2 | |
| EGSLMTKVIVKSNGT | 126 | Q05901 | |
| AVLRSKQTKSTIGVM | 46 | O95394 | |
| TKKLTACMSTVGLLQ | 881 | Q9P2K9 | |
| KVIAAMTVGKDVSSL | 36 | P63010 | |
| TSVGTLLAKMKTCVD | 4431 | Q9NR09 | |
| SLKKATMSTLTVDIA | 476 | Q86XM0 | |
| SVSGLTLKLMKTSVC | 301 | Q9NY47 | |
| SVSMTVKSIVLEKEL | 666 | P78363 | |
| SSLQGSAVTLKTSKM | 436 | Q9UNH5 | |
| VAKTKLANGTSSMIV | 106 | Q9Y297 | |
| MTTVENKSKISTGTA | 91 | Q69YQ0 | |
| LSVNEMTLSTLKEKG | 261 | Q12882 | |
| KVIASMTVGKDVSAL | 36 | Q10567 | |
| SMKKIVSTLSVAVVF | 666 | Q96K78 | |
| TISIELKKSGFMLSL | 826 | Q9UPY3 | |
| SSSVKTNLGVGKIAM | 726 | A2RUS2 | |
| LMVTSGYKAKTIVTA | 441 | Q14156 | |
| VTTLIASGVSIKMIT | 556 | P98194 | |
| LKDKSTLVAGSVVMA | 196 | O00203 | |
| KTTVFKSLGMAVEDT | 286 | Q14894 | |
| GSKVTLLLSSKTEMQ | 66 | Q9NTZ6 | |
| IDTQMAITKGSGKSL | 531 | Q6ZP01 | |
| MASGTTTTAVKIGII | 1 | Q13126 | |
| SISAKGAERVITLKM | 386 | P10276 | |
| SISAKGAERVITLKM | 386 | P10826 | |
| RMVILGSSKVGKTAI | 26 | Q9Y272 | |
| KELSVMFIETSAKTG | 146 | Q9NRW1 | |
| LSMKVTRKGSVISTL | 266 | Q52LD8 | |
| ETKVLKTLSVIMGVF | 291 | P21918 | |
| MLSVLSTLSGTIAIK | 311 | Q9NVH2 | |
| EKLESTMSLVKQLSG | 2651 | Q14571 | |
| IEGISKMTKLTRLSI | 946 | Q6ZRR7 | |
| KMTAILTTDVSDKAG | 1516 | Q01484 | |
| AKEATMKGSSSASIV | 691 | Q14126 | |
| ILSAKTKEEMASALV | 366 | Q5VWQ8 | |
| ITIITTKVMTSGTGA | 796 | P51610 | |
| VMSVGLVSVSKKSVS | 156 | Q96PD6 | |
| DTMVKAGVSTNISTK | 171 | P52948 | |
| MASLTAILKTNTVKV | 56 | Q9HA64 | |
| ALLSKKMTASSIIGE | 971 | Q9Y6X6 | |
| SSAKMGLVETKLAII | 201 | Q13825 | |
| TVMVSPVAKTGLKLT | 691 | Q5VTL7 | |
| LKGILKDNTSTTSSM | 11 | Q96PQ5 | |
| VTGAEIMRKLSKTHT | 2231 | Q2LD37 | |
| RKMLKTGLSTVVNST | 816 | Q8N6G6 | |
| STMERSELAKKIGTT | 1411 | Q10570 | |
| STLVETLMTGKRVKH | 1026 | Q5VYK3 | |
| TLSVTIEGPSKVKMD | 2416 | O75369 | |
| IIRSSKEKTTVTMVG | 511 | O60486 | |
| LKTMVETKKVTSSGV | 556 | P27815 | |
| TMVETKKVTSSGVLL | 531 | Q07343 | |
| LKTMVETKKVTSLGV | 511 | Q08493 | |
| KTMVETKKVTSSGVL | 586 | Q08499 | |
| GSGKTTVITILMKAQ | 2131 | Q96JB1 | |
| MGSSKKVTLSVLSRE | 1 | O00625 | |
| VVSAEKKLTGSTVGM | 201 | P53602 | |
| ISSMVLTKLKETAEA | 121 | P34931 | |
| TMKVTGVTTQGVKSL | 2256 | P00451 | |
| PTSAKEMTTKLGVTA | 921 | Q9ULI3 | |
| VMKALSVGLVKGSID | 311 | Q9UNM6 | |
| TSAMLLVTLGKVLKV | 186 | Q6P2C8 | |
| STIILLASSEMTKTK | 86 | Q8NDA8 | |
| VMTTGTDVKDAKVIS | 356 | P78563 | |
| PMEVGVSSKNVSLKT | 1636 | Q9C091 | |
| TTSMAKDVGLKITSV | 161 | Q70UQ0 | |
| IKGILKNKTSTTSSM | 11 | P41236 | |
| IIVTVVKMKSTVGSL | 221 | Q9H210 | |
| IVSSGFSSKMKVVAS | 331 | O43422 | |
| KLKSTIQRSTETGMA | 1461 | Q86UR5 | |
| PVSLEAQGKKMTVST | 286 | Q86YC2 | |
| LTETGTLKTSKLANM | 341 | Q9P2Q2 | |
| KGMSLSKITTTVGLN | 46 | Q13795 | |
| LAIKAITSSAKVDMT | 246 | Q14318 | |
| GVGATTVMLKEKLAE | 786 | Q9Y4L1 | |
| GIKSIVTLSMAKTEA | 1811 | Q9P2D3 | |
| TIGISKTVTEKNLML | 581 | Q9H799 | |
| ISMGLESSAISVVKI | 881 | Q13698 | |
| SMKGLRLTIAKQTVS | 266 | Q8IZS8 | |
| KSSTVGLVTLNDMKA | 61 | Q14320 | |
| ETAVIVETMIGKTKS | 641 | Q12934 | |
| SLATSISQMVKTEGK | 61 | Q9H0C8 | |
| KTKTLVSTCVILSGM | 6 | Q6P9A2 | |
| ITKIKTIGSTYMAAS | 971 | O60266 | |
| VDVISSAKITMASSL | 1686 | Q12955 | |
| LAEISTLAKMSSVKL | 16 | Q9H0A8 | |
| DVIIVTSSLTKDMTG | 101 | Q9UBF2 | |
| ISTDDMKKVGVTVVG | 946 | P29320 | |
| LKKVLSSMSLEVSLG | 146 | Q9H4E7 | |
| GIKSTSKSIMAAAGV | 161 | Q96RQ3 | |
| ATKGAVTAMTKALAL | 156 | Q9BPX1 | |
| DVIIVTSSLTKDMTG | 101 | Q9Y678 | |
| TSEMSKRDTLTIVKG | 6181 | Q8NDH2 | |
| MSTTGDKILDTALSK | 56 | P08397 | |
| RTSESKIMTDIISIG | 266 | Q9NQ60 | |
| STVVELMKKEGTTLG | 51 | Q9Y3R0 | |
| DARTVMKTGLESVKS | 3041 | Q92736 | |
| LITDTKSKMSKAAVS | 3431 | Q92736 | |
| SGIVDAKSSMVIKVD | 191 | Q6ZTR5 | |
| MQGKTSIDKLSLLVS | 146 | Q9HBV1 | |
| KDVESKMLSALLTGV | 476 | Q03701 | |
| VKVLSFTGTKTSLSM | 321 | Q14562 | |
| VGLSVMSVKKSSKCI | 101 | Q9H4L5 | |
| MLVVLSTEKTTISFG | 81 | Q8NH74 | |
| VTDLGKVTMIKTADL | 506 | Q6UXH9 | |
| KVLTGSLITKIGMAA | 136 | Q8NGK3 | |
| MDTTKTVLTGTKDTI | 606 | Q96Q06 | |
| MDTTKTVLTGTKDAV | 771 | Q96Q06 | |
| QMGVDTAKTVLTGTK | 801 | Q96Q06 | |
| VQTTMALGLSSKKAS | 6 | Q59EK9 | |
| SKVGKLTLKTTEMET | 156 | Q9Y230 | |
| MVLGSSVTDKKAIIL | 6 | P59551 | |
| ASMTIKSLLGKISLE | 2346 | O75691 | |
| IVEKVKGSITTMLAL | 721 | Q68CJ6 | |
| LSSSDLKMKVTSGRV | 361 | Q96DN5 | |
| VTVTKTDKTLVLLMG | 101 | P07737 | |
| ETVLTVTGKSVKEVM | 1286 | O95425 | |
| SSLSKGSMKKIEITV | 356 | Q8N5C8 | |
| PSAEGKMKVTVTQIT | 426 | Q8NDZ6 | |
| RNSATGKEISKSMIV | 396 | Q00889 | |
| IAIVGFSVTISMAKT | 346 | P58743 | |
| LTVISVKAVSGMITF | 221 | Q9H841 | |
| STSSIEKLMEALGAK | 301 | P00797 | |
| LSVMSKDTNGTRVKV | 376 | Q9ULN7 | |
| SKSMILTDVGKVTEP | 41 | Q53QZ3 | |
| IAVMTFDLTKITKTS | 56 | P04278 | |
| AVTVTTGRKAMTIVL | 326 | Q9H1N7 | |
| ISTSIITSTQKGMIK | 571 | P03915 | |
| AAGVTISSVEKKLMA | 96 | Q96C36 | |
| SMETTSIGKNISTKA | 411 | P49221 | |
| SAAESMISVVLGKKT | 196 | Q8NEZ3 | |
| VVMKLKKLESSVSTG | 41 | O75192 | |
| AMDLVSSAKTKVVVT | 426 | P55809 | |
| GKMVSKSIATTLIDD | 31 | O95379 | |
| KVMSAVKGIDGVSVT | 181 | Q9GZT8 | |
| GDTAVMVTAVSKTKP | 76 | Q8TCS8 | |
| LVKATSVVMSTTLAS | 616 | Q96KW2 | |
| TKAKIVLDIIVTMFS | 261 | Q9NSD9 | |
| TVTVEGMIKLALSTA | 296 | P36897 | |
| SEELMTIKLKATGGI | 906 | O60284 | |
| LLTAMKTDGATVKAA | 251 | P36956 | |
| LSDTTLEKKMAVASI | 26 | Q8TED9 | |
| GTIKKHTLSIGDMVT | 1026 | Q14690 | |
| MATSSEEVLLIVKKV | 1 | P32780 | |
| MKGSKAIRQTSELTL | 251 | Q9P2J8 | |
| DVAVKLKGTSTMLLT | 431 | Q9P2K2 | |
| STMDATAVAGIETKK | 376 | Q96CK0 | |
| EIKVTSGAKIMVVGS | 141 | O14562 | |
| KAGTATLAMSEKVRT | 146 | Q7Z3J2 | |
| KKSMVILTSSVTAGT | 1136 | P10745 | |
| IKSIVKSSLGMVESS | 456 | Q9NXC5 | |
| IGSKIKGVFKSTTME | 506 | Q9Y5W7 | |
| IKGILKNKTSTTSSM | 11 | Q6NXS1 | |
| LDTRTVMKSGSELVK | 2936 | Q15413 | |
| VVSNLKGISMSSSKL | 1301 | Q9Y490 | |
| MVTNVTSLLKTVKAV | 2121 | Q9Y490 | |
| VTMKKGDILTLLNST | 986 | Q13813 | |
| TQLKILSTVKATMLG | 1061 | P18206 | |
| IAGLSTMKTNLESLK | 261 | Q96SB8 | |
| TVKSLIGKGVMLAVS | 2491 | Q9P273 | |
| VTMKKGDVLTLLSSI | 996 | P02549 | |
| AIASTTMLVEKSLSV | 166 | Q9H0V1 | |
| LSGKASSEKEMTLIS | 521 | Q6AHZ1 | |
| AKLSTVKTMSEGTLA | 396 | Q5HYM0 | |
| MSSAKGEITSEVKRV | 416 | Q5HYM0 | |
| VKETLVIMKDVSSSL | 66 | P98182 | |
| TTISSNLTEMSKGVK | 581 | Q9Y4G6 | |
| KMVSSAKAAVPTVSD | 1001 | Q9Y4G6 | |
| VMVTNVTSLLKTVKA | 2121 | Q9Y4G6 | |
| IVGKSKLGVEMLSES | 266 | Q8N0Z9 | |
| LTGKMEKGLSSTIRV | 81 | Q8N3G9 | |
| AKDSVASTITGVMDK | 126 | Q99541 | |
| ASTITGVMDKTKGAV | 131 | Q99541 | |
| ASTLVILRKMGKSVD | 236 | Q2M3R5 | |
| ATMTQIKKLTGSTDR | 126 | A6NHJ4 | |
| IVLVTELMTSGTLKT | 271 | Q9Y3S1 | |
| KQKTSAALSTMGTLI | 91 | Q96J77 | |
| NTSSIGKEISTKMVG | 421 | Q96PF1 | |
| RTVAVKMLKEGATAS | 856 | P17948 | |
| VGSEAGMVLKVLAKT | 441 | Q8NFY4 | |
| GGMKETLSLTVDAKT | 796 | Q5H9R7 | |
| LMTGSETPSKVVIKL | 1841 | Q5VUA4 | |
| GAKMKTSASVSDIIV | 116 | Q9Y2Y6 | |
| MTTSTLQKAIDLVTK | 1 | Q9UN37 | |
| GMLKSAATKVTTVLA | 1316 | Q5THJ4 | |
| KSSTVGLVTLNDMKA | 61 | Q9Y247 | |
| KGKGSEVSVMLTVSA | 4776 | O14686 | |
| SAMLEASSTKVKEGT | 61 | Q96M32 | |
| SSLSTQDTLLIKKGM | 1046 | Q9NR99 |